GEDEON RICHTER ADR 144A 

$0.000000
105
+$0.00+0%Monday 00:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jun 2026
$2.14
Jun 2025
$1.47
Jun 2024
$1.18
Jun 2023
$1.14
Jun 2022
$0.60
10Y Growth
23.51%
5Y Growth
22.36%
3Y Growth
23.23%
1Y Growth
45.75%

Earnings

Nov 10Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.99
1.02
1.04
1.07
Expected EPS
N/A
Actual EPS
N/A

Financials

19.58%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
2.29BRevenue
449.25MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Gedeon Richter in various therapeutic areas.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a large pharmaceutical company with a wide range of products that compete with Gedeon Richter's offerings, especially in women's healthcare and central nervous system drugs.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap46.1B
Teva Pharmaceutical Industries is a leading generic and specialty pharmaceutical company that competes with Gedeon Richter in the generics market and in developing specialty medicines.
Merck
MRK
Mkt Cap356.01B
Merck & Co. is a global healthcare company that develops medicines, vaccines, biologic therapies, and animal health products, competing with Gedeon Richter in several therapeutic areas.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie operates in the pharmaceuticals industry, focusing on immunology, oncology, neuroscience, and virology, areas where Gedeon Richter also has significant interests.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines that compete with Gedeon Richter's product portfolio.
Sanofi
SNY
Mkt Cap95.65B
Sanofi is a global healthcare leader that offers a broad range of pharmaceuticals, competing with Gedeon Richter in areas like central nervous system and cardiovascular diseases.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline is a science-led global healthcare company that competes with Gedeon Richter in developing and marketing medications and vaccines.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson is a diversified healthcare company that produces pharmaceuticals, medical devices, and consumer health products, competing across multiple segments with Gedeon Richter.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Gedeon Richter in developing new medicines in oncology, cardiovascular, renal & metabolism, and respiratory.

About

Pharmaceuticals: Other
Health Technology
CHEMICAL WKS RICHTER GED
Show More
CEO
Gabor Orban
Employees
11955
Country
Hungary

Listings

0 Comments

Share your thoughts

FAQs

What is GEDEON RICHTER ADR 144A stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC MARKETS exchange GEDEON RICHTER ADR 144A stocks are traded under the ticker GEDRY.
What is GEDEON RICHTER ADR 144A revenue for the last year?▼
GEDEON RICHTER ADR 144A revenue for the last year amounts to 2.29B USD.
What is GEDEON RICHTER ADR 144A net income for the last year?▼
GEDRY net income for the last year is 449.25M USD.
Does GEDEON RICHTER ADR 144A pay dividends?▼
Yes, GEDRY dividends are paid annual. The last dividend per share was 1.17 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does GEDEON RICHTER ADR 144A have?▼
As of October 21, 2026, the company has 11,955 employees.
In which sector is GEDEON RICHTER ADR 144A located?▼
GEDEON RICHTER ADR 144A operates in the Health & Wellness sector.
When did GEDEON RICHTER ADR 144A complete a stock split?▼
The last stock split for GEDEON RICHTER ADR 144A was on July 23, 2013 with a ratio of 10:1.
Where is GEDEON RICHTER ADR 144A headquartered?▼
GEDEON RICHTER ADR 144A is headquartered in Budapest, Hungary.